VERIFY: Did Trump end the $35 monthly insulin cap?
by CBS19
Share on:
📚 Main Topics
- Executive Orders by President Trump
- Insulin Price Cap for Medicare Recipients
- Impact of the Inflation Reduction Act
- Role of Private Drug Manufacturers
✨ Key Takeaways
- President Trump signed several executive orders during his first week back in office, but none of these orders ended the $35 monthly cap on insulin prices for Medicare recipients.
- The $35 cap on insulin was established through the Inflation Reduction Act, meaning it would require new legislation from Congress to alter or eliminate it.
- Eli Lilly, a private drug manufacturer, has also implemented a $35 cap on insulin for those with commercial insurance and offers a savings card for uninsured individuals.
🧠Lessons
- Claims circulating on social media regarding changes to healthcare policies should be verified with credible sources.
- Legislative changes, especially regarding healthcare pricing, often require formal processes and cannot be altered solely through executive orders.
- Understanding the roles of both government and private entities in healthcare pricing is crucial for consumers, especially those reliant on essential medications like insulin.